Ardian

Santé Cie Group, a company in the French home medical assistance (HMA) market - offering medico-technical equipment, consumables and services to patients at home.

Prosol group is the founder of the chain of Grand Frais stores, which are located primarily on the outskirts of major cities and cover areas of 1,000sqm, embodying the concept of the traditional indoor covered market. Each large market hall supplies five different types of produce: fruit and vegetables, dairy, fish (Prosol group), meat produce and grocery (supported by specialized partners). Based in the Lyon region of France, Prosol group experiences a strong and steady growth, with a turnover of more than one billion euros and approximately 185 stores and offers a wide variety of quality fresh products at an attractive price.

Clever Age, established in 2001 and headquartered in Paris with subsidiaries in Lyon, Bordeaux, and Nantes, operates as a media service agency focusing on the entire digital production chain. The company is dedicated to providing interactive communication, technical architecture, production infrastructure, and web hosting services tailored for small and medium-sized enterprises. Its consultants possess extensive knowledge of market solutions, including content management systems and various technical frameworks, which enables them to deliver informed recommendations that align with clients' needs. By emphasizing independence, competitive intelligence, and research and development, Clever Age ensures that its solutions are both relevant and effective, helping clients navigate the complexities of technology and achieve high returns on investment. The firm specializes in Java/JEE, PHP, and Microsoft .Net architectures, allowing it to manage projects independently and address potential implementation challenges effectively.

Keolis is a prominent public transport operator active in 12 countries, including France, the UK, Sweden, Australia, Germany, Belgium, Denmark, Norway, the Netherlands, Canada, Portugal, and the USA. The company specializes in designing and operating diverse mobility solutions tailored to local needs, encompassing services such as automatic metros, trams, buses, coaches, ferries, and bike-sharing systems. Keolis manages over 80 urban networks in France, including major cities like Lyon, Lille, Bordeaux, and Rennes, and holds significant rail franchises in the UK, serving more than 30% of the nation's passengers. Its Australian subsidiary operates Yarra Trams in Melbourne, the largest tram system globally, while its rail services extend to the Virginia Railway Express in Washington, DC. As of 2010, Keolis reported a turnover of 4.1 billion euros, with nearly half generated from international operations, and employed approximately 47,200 people. The company is primarily owned by SNCF, with additional stakes held by Axa Private Equity and CDPQ.

ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company based in Lyon, France, founded in 2004. The company specializes in the development of red blood cell-based therapeutics aimed at treating cancer and orphan diseases. Its lead product candidate, eryaspase, is currently undergoing Phase III clinical trials for second-line pancreatic cancer and Phase II trials for triple-negative breast cancer. Additionally, ERYTECH is developing erymethionase, a preclinical candidate targeting methionine-dependent cancers, which consists of methionine-gamma-lyase encapsulated in red blood cells. The company collaborates with research institutions such as the Fox Chase Cancer Center and Queen’s University of Canada to enhance the preclinical development of its products for conditions like homocystinuria and arginase-1 deficiency, respectively. Through its innovative approach to encapsulating therapeutic molecules, ERYTECH Pharma aims to improve the efficacy and safety of its treatments.